内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

梅斯作为媒体参与第二届国际淋巴学研讨会于17年3月18-19日在沪举行

2016-12-26 MedSci MedSci原创

淋巴学刘宁飞
关注

尊敬的同道们：  第二届国际淋巴学研讨会-高峰对话将于2017年3月18-19日在上海召开。此次大会邀请了国际淋巴学会秘书长M Wittle教授,CDT治疗的创始人E Foeldi教授，淋巴而是看人领军者C Becker教授等国际顶尖的淋巴学者。会议聚焦淋巴水肿的临床新进展，包括淋巴系统影像学诊断，显微淋巴外科和淋巴水肿综合消肿治疗（CDT）的成就。本次论坛将搭建临床淋巴学学术交流平台，



第二届国际淋巴学研讨会-高峰对话将于2017年3月18-19日在上海召开。此次大会邀请了国际淋巴学会创始人之一M Wittle教授,CDT治疗的创始人E Foeldi教授，淋巴外科领军者之一Becker教授等国际顶尖的淋巴学者。在我国淋巴类疾病的患者达到千万级别，在此形势下淋巴学在我国开始推广起来，正在日益被医护人员所重视，此次会议是对疾病的防治和提高医护人员的水平一个很好的学习机会，会议期间会阐述淋巴类疾病的影像、诊断、手术和非手术治疗等诸多内容，让我们在3月18日共同见证这一次具有历史意义的会议。





梅斯医学（MedSci）：愿景是致力于改善医疗质量，为临床实践提供智慧、精准的决策支持，让医生与患者受益。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1994738, encodeId=79e81994e38bd, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Aug 03 10:32:00 CST 2017, time=2017-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276945, encodeId=243212e69458e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Dec 28 00:32:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580290, encodeId=da4a15802905c, content=<a href='/topic/show?id=a00065950b4' target=_blank style='color:#2F92EE;'>#淋巴学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65950, encryptionId=a00065950b4, topicName=淋巴学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50f116619411, createdName=more is better!, createdTime=Wed Dec 28 00:32:00 CST 2016, time=2016-12-28, status=1, ipAttribution=)]
    2017-08-03 kcb069

    #研讨会#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1994738, encodeId=79e81994e38bd, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Aug 03 10:32:00 CST 2017, time=2017-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276945, encodeId=243212e69458e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Dec 28 00:32:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580290, encodeId=da4a15802905c, content=<a href='/topic/show?id=a00065950b4' target=_blank style='color:#2F92EE;'>#淋巴学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65950, encryptionId=a00065950b4, topicName=淋巴学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50f116619411, createdName=more is better!, createdTime=Wed Dec 28 00:32:00 CST 2016, time=2016-12-28, status=1, ipAttribution=)]
    2016-12-28 一闲

    #梅斯#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1994738, encodeId=79e81994e38bd, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Aug 03 10:32:00 CST 2017, time=2017-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276945, encodeId=243212e69458e, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Dec 28 00:32:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580290, encodeId=da4a15802905c, content=<a href='/topic/show?id=a00065950b4' target=_blank style='color:#2F92EE;'>#淋巴学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65950, encryptionId=a00065950b4, topicName=淋巴学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50f116619411, createdName=more is better!, createdTime=Wed Dec 28 00:32:00 CST 2016, time=2016-12-28, status=1, ipAttribution=)]
    2016-12-28 more is better!

    #淋巴学#

    0